Bellevue Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.5M | Buy |
169,366
+80,003
| +90% | +$7.14M | 0.37% | 57 |
|
|
2026
Q1 | $6.42M | Sell |
89,363
-19,695
| -18% | -$1.52M | 0.15% | 67 |
|
|
2025
Q4 | $8.65M | Buy |
109,058
+57,859
| +113% | +$4.56M | 0.16% | 66 |
|
|
2025
Q3 | $3.86M | Buy |
51,199
+21,103
| +70% | +$1.45M | 0.08% | 83 |
|
|
2025
Q2 | $2.08M | Sell |
30,096
-1,659
| -5% | -$109K | 0.05% | 95 |
|
|
2025
Q1 | $2.15M | Buy |
31,755
+9,911
| +45% | +$593K | 0.05% | 100 |
|
|
2024
Q4 | $981K | Sell |
21,844
-222
| -1% | -$12.5K | 0.02% | 117 |
|
|
2024
Q3 | $1.39M | Hold |
22,066
| – | – | 0.02% | 111 |
|
|
2024
Q2 | $1.3M | Hold |
22,066
| – | – | 0.02% | 116 |
|
|
2024
Q1 | $1.76M | Sell |
22,066
-9,437
| -30% | -$721K | 0.03% | 110 |
|
|
2023
Q4 | $2.49M | Sell |
31,503
-3,811
| -11% | -$271K | 0.04% | 104 |
|
|
2023
Q3 | $2.47M | Hold |
35,314
| – | – | 0.04% | 108 |
|
|
2023
Q2 | $2.44M | Buy |
35,314
+12,500
| +55% | +$889K | 0.03% | 110 |
|
|
2023
Q1 | $1.7M | Sell |
22,814
-181,391
| -89% | -$15.2M | 0.02% | 119 |
|
|
2022
Q4 | $19M | Sell |
204,205
-20,909
| -9% | -$2.02M | 0.25% | 87 |
|
|
2022
Q3 | $21.5M | Sell |
225,114
-4,039
| -2% | -$400K | 0.31% | 79 |
|
|
2022
Q2 | $21.2M | Sell |
229,153
-3,202
| -1% | -$313K | 0.3% | 85 |
|
|
2022
Q1 | $23.5M | Buy |
232,355
+3,557
| +2% | +$374K | 0.27% | 90 |
|
|
2021
Q4 | $23.6M | Buy |
228,798
+70,250
| +44% | +$6.49M | 0.24% | 98 |
|
|
2021
Q3 | $13.5M | Sell |
158,548
-1,600
| -1% | -$134K | 0.14% | 107 |
|
|
2021
Q2 | $13.4M | Buy |
160,148
+35,600
| +29% | +$2.92M | 0.13% | 120 |
|
|
2021
Q1 | $9.37M | Buy |
124,548
+3,953
| +3% | +$288K | 0.1% | 123 |
|
|
2020
Q4 | $8.24M | Sell |
120,595
-66,386
| -36% | -$4.32M | 0.09% | 120 |
|
|
2020
Q3 | $10.9M | Sell |
186,981
-44,700
| -19% | -$2.78M | 0.15% | 106 |
|
|
2020
Q2 | $15.1M | Buy |
231,681
+18,700
| +9% | +$1.18M | 0.21% | 89 |
|
|
2020
Q1 | $12.6M | Buy |
212,981
+5,702
| +3% | +$381K | 0.25% | 75 |
|
|
2019
Q4 | $15.4M | Buy |
207,279
+101,591
| +96% | +$7.13M | 0.24% | 71 |
|
|
2019
Q3 | $6.67M | Buy |
105,688
+46,362
| +78% | +$2.75M | 0.12% | 101 |
|
|
2019
Q2 | $3.23M | Buy |
59,326
+1,699
| +3% | +$91.5K | 0.06% | 118 |
|
|
2019
Q1 | $3.11M | Buy |
57,627
+31,802
| +123% | +$1.96M | 0.17% | 93 |
|
|
2018
Q4 | $1.69M | Buy |
25,825
+17,825
| +223% | +$1.33M | 0.11% | 100 |
|
|
2018
Q3 | $630K | Hold |
8,000
| – | – | 0.04% | 135 |
|
|
2018
Q2 | $515K | Sell |
8,000
-800
| -9% | -$52.7K | 0.04% | 132 |
|
|
2018
Q1 | $547K | Hold |
8,800
| – | – | 0.05% | 118 |
|
|
2017
Q4 | $638K | Hold |
8,800
| – | – | 0.07% | 119 |
|
|
2017
Q3 | $716K | Sell |
8,800
-24,600
| -74% | -$1.95M | 0.07% | 115 |
|
|
2017
Q2 | $2.69M | Hold |
33,400
| – | – | 0.32% | 71 |
|
|
2017
Q1 | $2.62M | Buy |
33,400
+23,700
| +244% | +$1.89M | 0.35% | 70 |
|
|
2016
Q4 | $765K | Hold |
9,700
| – | – | 0.16% | 97 |
|
|
2016
Q3 | $863K | Sell |
9,700
-70,100
| -88% | -$6.62M | 0.16% | 98 |
|
|
2016
Q2 | $7.64M | Sell |
79,800
-6,400
| -7% | -$638K | 1.44% | 23 |
|
|
2016
Q1 | $8.94M | Buy |
+86,200
| New | +$8.38M | 1.62% | 17 |
|
Other funds holding CVS
Bellevue Group's CVS Position: Q2 2026 in Review
Bellevue Group increased its CVS Health (CVS) stake by 90% in Q2 2026, buying an estimated $7.14M and bringing the position to 169,366 shares worth $17.5M. The position accounts for 0.37% of the portfolio, ranked #57.
Bellevue Group first reported a position in CVS in Q1 2016 and has held it in 42 quarters since. The position peaked at $23.6M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Bellevue Group held 169,366 shares of CVS Health worth $17.5M as of Q2 2026.
- Bellevue Group bought 80,003 CVS Health shares in Q2 2026, an estimated $7.14M.
- CVS Health made up 0.37% of Bellevue Group's portfolio in Q2 2026, its #57 holding.
- Bellevue Group first reported a position in CVS Health in Q1 2016 and has held it in 42 quarters since.
- Bellevue Group's CVS Health position peaked at $23.6M in Q4 2021.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Bellevue Group's 13F filing for Q2 2026, filed 14 Aug 2026.